KBI Biopharma
Marykay (Eifried Pence) Marchigiani, CPA, is an accomplished financial executive with extensive experience in various leadership roles. Currently serving as Chief Financial Officer at KBI Biopharma, Marykay has previously held significant positions including EVP and Chief Operating Officer as well as Chief Financial Officer at ABL Inc., and CFO and Director of Business Operations at BNBI. Additionally, Marykay was Chief Financial Officer at Censeo Consulting Group and served as Director of Government Accounting and G&A at MedImmune, the global biologics research and development arm of AstraZeneca. Marykay holds a Bachelor of Science degree in Finance from Virginia Tech and is a graduate of Radford High School in Radford, Virginia.
This person is not in any offices
KBI Biopharma
6 followers
KBI Biopharma is a Global Contract Development & Manufacturing Organization (CDMO|CMO) offering Cell Line Development, Process Analytical & Formulation Development, Clinical & Commercial Manufacturing, Characterization & Cell Therapy services.